On July 29, 2025, Avadel Pharmaceuticals held its Annual Shareholders Meeting, where directors were elected and Deloitte & Touche was ratified as the auditor for the fiscal year 2025, with 83,659,463 shares represented. A total of 96,892,985 shares could vote, and the directors elected will serve until the 2026 Annual Meeting.